Overview
About the Company
Gritstone bio was founded in 2015, and was originally known as Gritstone Oncology, Inc. Early on, the company focused primarily on cancer treatments before expanding its operations into infectious diseases. Gritstone bio’s objective is to create innovative, effective treatments and vaccines for a variety of diseases and illnesses. The company holds offices in several U.S. locations, including Boston, Massachusetts, and Pleasanton, California. Gritstone bio’s corporate headquarters is located in Emeryville, California, and its current CEO is Andrew Allen, M.D., Ph.D.
Gritstone bio is involved in the research and development of immunotherapies for cancers and infectious diseases. Prospective employees will find job openings in many of Gritstone bio’s U.S. locations, with career opportunities in areas such as human resources, research...